| Application no. and date | 17748044.9 (espacenet) (Federated) (European Patent Register), 20170201 | | Patent/reg. no. and date | DK/EP 3411411, 20210519 | | Publication date | 20181212 | | Priority no. and date | US 201662289653 P, 20160201 | | EP pub. no. and date |
EP 3411411 20181212 | | Effective date | | | Applicant/owner | Biocryst Pharmaceuticals, Inc., 4505 Emperor Blvd.
Durham, North Carolina 27703, US | | Applicant ref. no. | 163843/BT/CB | | Inventor | BABU, Yarlagadda, S., 4836 Southlake Parkway
Birmingham
AL 35244, US,
ZHANG, Weihe, 2645 Manchester Court
Vestavia
AL 35226, US,
WU, Minwan, 2709 Paden Trail
Vestavia Hills
AL 35226, US,
RAMAN, Krishnan, 3739 Spearman Drive
Birmingham
AL 35244, US,
KOTIAN, Pravin, L., 1139 Magnolia Run
Hoover, Alabama 35226, US,
VOGETI, Lakshminarayana, 905 Congressional Drive
Lawrence, Kansas 66049, US,
CHINTAREDDY, Venkat, R., 3134 Renfro Road
Vestavia Hills, Alabama 35216, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4035 (2006.01) , A61K 31/404 (2006.01) , A61K 31/416 (2006.01) , A61K 31/4439 (2006.01) , A61P 13/12 (2006.01) , A61P 21/04 (2006.01) , A61P 25/00 (2006.01) , A61P 25/28 (2006.01) , A61P 37/00 (2006.01) , A61P 37/06 (2006.01) , A61P 9/00 (2006.01) , C07D 209/40 (2006.01) , C07D 209/42 (2006.01) , C07D 209/48 (2006.01) , C07D 231/56 (2006.01) , C07D 401/12 (2006.01) , C07D 403/04 (2006.01) , C07D 403/06 (2006.01) , C07D 403/12 (2006.01) , C07D 471/04 (2006.01) , C07D 487/04 (2006.01) , A61P 13/00 (2006.01) , C07D 209/12 (2006.01) , C07D 401/04 (2006.01) , C07D 401/06 (2006.01) , C07D 401/14 (2006.01) , C07D 405/12 (2006.01) | | Title | 1H-INDAZOL-3-CARBOXAMIDDERIVATER OG BESLÆGTEDE FORBINDELSER SOM FAKTOR D-INHIBITORER TIL BEHANDLING AF SYGDOMME, DER ER KENDETEGNET VED ABERRERENDE KOMPLEMENTSYSTEMAKTIVITET, SÅSOM F.EKS. IMMUNOLOGISKE LIDELSER | | Int. application no. | US2017015953 | | Int. publication no. | WO2017136395 | | Related patent (certificate) | | | Status | DK/EP patent med begrænsede krav | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
